These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 11521878)
1. Separation of antithrombin III variants by micellar electrokinetic chromatography. Dönges R; Römisch J; Stauss H; Brazel D J Chromatogr A; 2001 Jul; 924(1-2):307-13. PubMed ID: 11521878 [TBL] [Abstract][Full Text] [Related]
2. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin. Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302 [TBL] [Abstract][Full Text] [Related]
3. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy. Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding. Peterson CB; Blackburn MN J Biol Chem; 1985 Jan; 260(1):610-5. PubMed ID: 3965464 [TBL] [Abstract][Full Text] [Related]
5. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography. Heger A; Grunert T; Schulz P; Josic D; Buchacher A Thromb Res; 2002 Apr; 106(2):157-64. PubMed ID: 12182916 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding. Jørgensen M; Petersen LC; Thorsen S J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440 [TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction. Pletcher CH; Cunningham M; Nelsestuen GL Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296 [TBL] [Abstract][Full Text] [Related]
9. Purification and properties of guinea pig antithrombin III. Heck L; Rosenberg R; Remold H Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072 [TBL] [Abstract][Full Text] [Related]
10. Pasteurisation induced changes in an antithrombin III concentrate. Winkelman L; Haddon ME Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862 [TBL] [Abstract][Full Text] [Related]
11. The interaction of protein-bound heparin and antithrombin III. Shanberge JN; Sridhar CN Ann N Y Acad Sci; 1981; 370():708-13. PubMed ID: 6168228 [TBL] [Abstract][Full Text] [Related]
12. Conditions for radioiodination of antithrombin III retaining its biological properties. Caix J; Perrot Minnot A; Beziade A; Vuillemin L; Belloc F; Baquey C; Ducassou D Int J Rad Appl Instrum A; 1987; 38(12):1003-6. PubMed ID: 2828272 [TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of rat plasma antithrombin III. Takahara H; Sinohara H Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830 [TBL] [Abstract][Full Text] [Related]
14. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509 [TBL] [Abstract][Full Text] [Related]
15. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity. Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007 [TBL] [Abstract][Full Text] [Related]
16. Affinity chromatography in the separation of human alpha 1-antitrypsin (alpha 1-AT) and antithrombin-III (AT-III). D'Souza S; Ananthakrishnan R Aust J Exp Biol Med Sci; 1979 Jun; 57(3):245-50. PubMed ID: 316999 [TBL] [Abstract][Full Text] [Related]
17. Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule. Niewiarowski S; Rucinski B; James P; Lindahl U FEBS Lett; 1979 Jun; 102(1):75-8. PubMed ID: 456593 [No Abstract] [Full Text] [Related]
18. Quantification of antithrombin isoform proportions in plasma samples of healthy subjects, sepsis patients, and in antithrombin concentrates. Römisch J; Dönges R; Stauss H; Inthorn D; Mühlbayer D; Jochum M; Hoffmann J Pathophysiol Haemost Thromb; 2002; 32(3):143-50. PubMed ID: 12372930 [TBL] [Abstract][Full Text] [Related]
19. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin]. Kudriashov BA; Pastorova VE; Liapina LA Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530 [TBL] [Abstract][Full Text] [Related]
20. Structure of the antithrombin-binding site in heparin. Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]